Kidney and Blood Pressure Research

Original Paper

Risk Stratification for Renal Transplantation after Cardiac or Lung Transplantation: Single-Center Experience and Review of the Literature

Rosenberger C.a · Stein J.b · Jürgensen J.S.a · Eibl N.a · Babel N.a · Bachmann U.a · Kemper D.b · Knosalla C.b · Hetzer R.b · Frei U.a · Lehmkuhl H.b · Reinke P.a

Author affiliations

aNephrology and Medical Intensive Care, Charité Universitätsmedizin, and bGerman Heart Institute, Berlin, Germany

Related Articles for ""

Kidney Blood Press Res 2007;30:260–266

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 07, 2006
Accepted: May 22, 2007
Published online: June 29, 2007
Issue release date: July 2007

Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 2

ISSN: 1420-4096 (Print)
eISSN: 1423-0143 (Online)

For additional information: https://www.karger.com/KBR

Abstract

Background: Long-term survival after heart (HTx) or lung (LuTx) transplantation increases the risk for end-stage renal disease (ESRD). After HTx ESRD was reported to enhance mortality, and kidney transplantation (KTx) was shown to improve survival. However, prognostic factors in ESRD after HTx or LuTx are largely unknown. Methods: Single-center observational study in HTx and LuTx patients who accessed the KTx waiting list; baseline characteristics were correlated with mortality. Results: KTx was performed in 15 of 65 study patients. Survival was comparable on the KTx waiting list and in reference patients from the same center without ESRD. KTx significantly improved survival (5 years’ survival 84.6% with KTx vs. 56.5% on the KTx waiting list, p = 0.030). None of the baseline parameters predicted mortality in the KTx group. Only on the KTx waiting list BMI (median 24.7 vs. 20.7; p < 0.05) and left ventricular ejection fraction (LVEF, median 63 vs. 53%, p < 0.008) significantly correlated with survival. Conclusions: The risk for mortality after HTx or LuTx is not increased by ESRD, provided that patients meet access criteria for the KTx waiting list. KTx improves survival in ESRD after HTx or LuTx. BMI and LVEF may predict outcome in HTx/LuTx patients on the KTx waiting list.

© 2007 S. Karger AG, Basel




Related Articles:


References

  1. Ojo AO, Held PJ, Port FK, et al: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931–940.
  2. Shiba N, Chan MC, Kwok BW, Valantine HA, Robbins RC, Hunt SA: Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. J Heart Lung Transplant 2004;23:155–164.
  3. Kirklin JK, Naftel DC, Bourge RC, McGiffin DC, et al: Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study. Cardiothorac Transplant 2003;125:881–890.
  4. John R, Rajasinghe HA, Chen JM, et al: Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg 2001;72:440–449.
  5. Senechal M, Dorent R, du Montcel ST, et al: End-stage renal failure and cardiac mortality after heart transplantation. Clin Transplantation 2004;18:1–6.
  6. Van Gelder T, Balk AHMM, Zietse R, Hesse C, Mochtar B, Weimar W: Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant 1998;13:2322–2326.
  7. Satchitahananda DK, Parameshwar J, Sharples L, et al: The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. J Heart Lung Transplant 2002;21:651–657.
  8. Veillon S, Caillard S, Epailly E, Eisenmann B, Hannedouche T, Moulin B: Chronic renal failure after cardiac transplantation: predictive factors and influence on mortality: results of a monocenter study in 141 patients. Transplant Proc 2002;34:2819–2820.
  9. Coopersmith CM, Brennan DC, Miller B, et al: Renal transplantation following previous heart, liver, and lung transplantation: an 8-year single-center experience. Surgery 2001;130:457–462.
  10. Myers J, Geiran O, Simonsen S, Ghuyoumi A, Gullestad L: Clinical and exercise test determinants of survival after cardiac transplantation. Chest 2003;124:2000–2005.
  11. Fraund S, Pethig K, Franke U, et al: Ten year survival after heart transplantation: palliative procedure or successful long term treatment? Heart 1999;82:47–51.
  12. Sarnak MJ: Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003;41:S11–S17.
  13. Kalantar-Zadeh K, Block G, Horvich T, Fonarow GC: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004;43:1439–1444.
  14. Kuhlmann MK, Levin NW: Interaction between nutrition and inflammation in hemodialysis patients; in Ronco C, Brendolan A, Levin NW (eds): Cardiovascular Disorders in Hemodialysis. Contrib Nephrol. Basel, Karger, 2005, vol 149, p 200–207.
  15. Longenecker JC, Coresh J, Powe NR, et al: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002;13:1918–1927.
  16. Grady KL, Naftel D, Pamboukian SV, et al: Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: Multi-institutional study of post-operative weight change. J Heart Lung Transplant 2005;24:1424–1430.
  17. Abbott KC, Glanton CW, Trespalacios FC, et al: Body mass index, dialysis modality, and survival: analysis of the United States renal Data System Morbidity and Mortality Wave II Study. Kidney Int 2004;65:597–605.
  18. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208–2218.
  19. Coco M, Rush H: Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000;36:1115–1121.
  20. Dwyer JT, Larive B, Leung J, et al: Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study? Kidney Int 2005;68:1766–1776.
  21. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al: Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005;46:489–500.
  22. Wilhelmi M, Pethig K, Wilhelmi M, Nguyen H, Struber M, Haverich A: Heart transplantation: echocardiographic assessment of morphology and function after more than 10 years of follow-up. Ann Thorac Surg 2002;74:1075–1079.
  23. John R, Rajasinghe HA, Itescu S, et al: Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era. J Am Coll Cardiol 2001;37:189–194.
  24. Verhoeven PP, Lee FA, Ramahi TM, et al: Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation. J Am Coll Cardiol 1996;28:183–189.
  25. Radovancevic B, Radovancevic R, Vrtovec B, Thomas CD, Frazier OH: Outcomes in patients with low left ventricular ejection fraction after heart transplantation. Eur J Cardiol Thorac Surg 2003;23:743–747.
  26. Hershberger RE, Ni H, Toy W, Wilson RA: Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality. J Heart Lung Transplant 2001;20:417–424.
  27. Barbir M, Lazem F, Banner N, Mitchell A, Yacoub M: The prognostic significance of non-invasive cardiac tests in heart transplant recipients. Eur Heart J 1997;18:692–696.
  28. Wali RK, Wang GS, Gottlieb SS, et al: Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 2005;45:1051–1060.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 07, 2006
Accepted: May 22, 2007
Published online: June 29, 2007
Issue release date: July 2007

Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 2

ISSN: 1420-4096 (Print)
eISSN: 1423-0143 (Online)

For additional information: https://www.karger.com/KBR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP